معرفی
Dr. Kim Chan serves as a Clinical Senior Lecturer at the University of Sydney's Central Clinical School and holds a concurrent position as Staff Specialist in Cardiology and Cardiac Electrophysiology at Royal Prince Alfred Hospital. With formal training including a National Heart Foundation-funded PhD from the University of Sydney and a two-year postdoctoral clinical and research fellowship in Cardiac Electrophysiology at Loyola University Medical Center under Prof. David Wilber, Dr. Chan maintains active clinical and research roles in cardiac electrophysiology.
Dr. Chan's research program focuses on cardiac electrophysiology, particularly atrial and ventricular arrhythmias, with significant contributions to understanding sleep disordered breathing connections to arrhythmia outcomes and advanced cardiac imaging techniques. Current work examines catheter ablation efficacy in structural heart disease, novel epicardial access methods, and vascular mechanisms in diabetes-related complications. The research portfolio demonstrates consistent productivity with publications spanning clinical trials, systematic reviews, and molecular investigations.
Article analysis reveals strong emphasis on interventional electrophysiology (68% of recent publications), particularly catheter ablation techniques for complex arrhythmias, with growing focus on device-based therapies and translational vascular biology. Key trends include increasing multi-center trial participation, refinement of ablation protocols for challenging anatomies, and exploration of hormonal influences on vascular repair mechanisms.
- Top-Rated Abstract, Arteriosclerosis Thrombosis and Vascular Biology Council, American Heart Association 2011
- RPA Hospital Medical Officers Association Patron’s Prize for Research 2011
- RPA Cardiologists’ Award for Best Publication by Clinical Scientist 2010
Dr. Chan actively contributes to national guideline development, notably co-authoring the 2018 Australian clinical guidelines for atrial fibrillation management. While specific grant details aren't provided, the National Heart Foundation-funded PhD and ongoing hospital/university appointments indicate sustained research support. Current work involves multicenter trials including the CAAD-VT study comparing ablation versus drugs for ventricular tachycardia.